We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.07%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.3B
AUM Growth
-$803M
Cap. Flow
+$159M
Cap. Flow %
0.82%
Top 10 Hldgs %
30.79%
Holding
732
New
52
Increased
325
Reduced
233
Closed
41

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$78.3M
2
NEE icon
NextEra Energy
NEE
+$57M
3
NVDA icon
NVIDIA
NVDA
+$48M
4
BABA icon
Alibaba
BABA
+$43.4M
5
AAPL icon
Apple
AAPL
+$39M

Top Sells

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$87.5M
2
RVMD icon
Revolution Medicines
RVMD
+$45.5M
3
ABT icon
Abbott
ABT
+$44.5M
4
JPM icon
JPMorgan Chase
JPM
+$44.3M
5
IQV icon
IQVIA
IQV
+$43M

Sector Composition

Rank Sector Weight
1 Technology 32.73%
2 Healthcare 27.11%
3 Financials 9.44%
4 Consumer Discretionary 7.72%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTU icon
276
Intuit
INTU
$79.3B
$10.4M 0.05%
24,073
-2,264
-9% -$1.08M
COF icon
277
Capital One
COF
$127B
$10.4M 0.05%
57,034
-16,644
-23% -$3.48M
SMMT icon
278
Summit Therapeutics
SMMT
$11.4B
$10.3M 0.05%
540,662
CME icon
279
CME Group
CME
$85.8B
$10.2M 0.05%
34,622
-322
-0.9% -$95.6K
VIR icon
280
Vir Biotechnology
VIR
$1.59B
$10.2M 0.05%
1,135,763
+104,100
+10% +$829K
WTS icon
281
Watts Water Technologies
WTS
$11.4B
$10M 0.05%
34,579
+7,256
+27% +$2.21M
SLB icon
282
SLB Ltd
SLB
$69.7B
$9.92M 0.05%
192,967
-20,248
-9% -$983K
HWM icon
283
Howmet Aerospace
HWM
$112B
$9.77M 0.05%
42,409
-8,390
-17% -$1.96M
SNEX icon
284
StoneX
SNEX
$8.86B
$9.69M 0.05%
180,283
+116,387
+182% +$5.88M
PODD icon
285
Insulet
PODD
$11.3B
$9.6M 0.05%
45,769
-20,733
-31% -$5.21M
SION
286
Sionna Therapeutics
SION
$2.13B
$9.49M 0.05%
+236,813
New +$9.04M
CMCSA icon
287
Comcast
CMCSA
$85.1B
$9.44M 0.05%
328,918
+18,284
+6% +$547K
SLNO
288
DELISTED
Soleno Therapeutics
SLNO
$9.43M 0.05%
+281,620
New +$11M
AMT icon
289
American Tower
AMT
$76.1B
$9.36M 0.05%
54,243
+2,485
+5% +$447K
SNOW icon
290
Snowflake
SNOW
$94.2B
$9.23M 0.05%
61,199
-1,586
-3% -$294K
TRVI icon
291
Trevi Therapeutics
TRVI
$2.58B
$9.23M 0.05%
+773,620
New +$8.66M
MET icon
292
MetLife
MET
$60.1B
$9.19M 0.05%
129,945
-4,219
-3% -$316K
ITT icon
293
ITT
ITT
$17.1B
$9.16M 0.05%
48,094
+8,311
+21% +$1.58M
AN icon
294
AutoNation
AN
$6.64B
$9.15M 0.05%
46,864
-556
-1% -$112K
GLW icon
295
Corning
GLW
$140B
$9.08M 0.05%
66,791
-5,490
-8% -$662K
UPS icon
296
United Parcel Service
UPS
$98.9B
$8.95M 0.05%
91,015
+20,791
+30% +$2.23M
MRSH
297
Marsh
MRSH
$87.5B
$8.95M 0.05%
51,591
+2,073
+4% +$373K
DAR icon
298
Darling Ingredients
DAR
$10.2B
$8.86M 0.05%
143,192
+128,344
+864% +$6.32M
CLDX icon
299
Celldex Therapeutics
CLDX
$2.8B
$8.85M 0.05%
+278,888
New +$7.6M
MBX
300
MBX Biosciences
MBX
$2.87B
$8.79M 0.05%
+294,374
New +$10M

Similar funds

Candriam SCA's Q1 2026 Portfolio in Review

As of Q1 2026, Candriam SCA held 732 positions worth $19.3B, down 4% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q1 2026 filing shows 52 new, 325 increased, 233 reduced and 41 closed positions. Its largest new stake was Service Corp International: 360,195 shares worth $29.7M. The largest sale was Nu Holdings, an estimated $87.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2026 buy was Service Corp International: 360,195 shares worth $29.7M.
  • Candriam SCA added most to KLA in Q1 2026, an estimated $78.3M increase.
  • Candriam SCA's biggest Q1 2026 reduction was Nu Holdings, cutting an estimated $87.5M.
  • Candriam SCA fully exited Banco Macro in Q1 2026, selling an estimated $25.6M.
  • Candriam SCA's ten largest holdings make up 31% of its $19.3B portfolio in Q1 2026.
  • Candriam SCA opened 52 new positions and closed 41 in Q1 2026.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $19.3B.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.